OncoMatch/Clinical Trials/NCT06381960
Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe
Is NCT06381960 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Fuzheng Quxie Recipe and Fuzhengquye Fang Recipe simulant for lung cancer.
Treatment: Fuzheng Quxie Recipe · Fuzhengquye Fang Recipe simulant — To address the clinical challenge of postoperative metastasis in stage IIA-IIIA non-small cell lung cancer with negative driver gene expression, there is a lack of effective diagnostic and therapeutic measures. Based on this, investigators propose to carry out a clinical study on the prevention and treatment of postoperative metastasis of IIA-IIIA stage lung cancer with negative driver gene expression with the formula of supporting the positive and dispelling the evil.
Check if I qualifyExtracted eligibility criteria
Cancer type
Non-Small Cell Lung Carcinoma
Biomarker criteria
Required: ALK wild-type
Required: PD-L1 (CD274) expression <1% (<1%)
Required: EGFR wild-type
Required: PDCD1 expression <1% (<1%)
Required: ROS1 wild-type
Disease stage
Required: Stage IIA, IIB, IIIA
clinical stage IIA-IIIA lung adenocarcinoma after radical surgery
Performance status
OTHER 0–2
Prior therapy
Must have received: radical surgery
after radical surgery (patients within 6 weeks after surgery)
Lab requirements
Blood counts
white blood cell count >3.5 × 10^9/L and <12 × 10^9/L, platelet count >80 × 10^9/L, erythrocyte pressure area >0.20
Kidney function
creatinine <350 μmol/L
Liver function
blood bilirubin <68 μmol/L, aspartate aminotransferase <90 IU/L
Cardiac function
no serious heart disease
Patients with basically normal blood and biochemical indices, etc., without serious viral or bacterial infections; patients without organ failure and serious heart disease (blood bilirubin <68 μmol/L, aspartate aminotransferase <90 IU/L, creatinine <350 μmol/L, white blood cell count >3.5 × 10^9/L and less than 12 × 10^9/L, platelet count >80 × 10^9/L, and (erythrocyte pressure area >0.20)
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify